OLK Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.25% compare to its pairs and should correct upwards.

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research...

Stats
Šios dienos apimtis	279 742
Vidutinė apimtis	422 791
Rinkos kapitalizacija	3.17B
EPS	$-0.130 ( Q1 \| 2024-05-13 )
Kita pelno data	( $-0.110 ) 2024-08-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-94.37 (Sector) 42.63 (Industry) 0
ATR14	$0.0120 (0.05%)

ACRS -0.90%

AKU -17.87%

APDN -0.73%

BDSX 2.00%

BIOC 0.00%

BNGO -7.69%

BNR 1.05%

CDNA 7.92%

CEMI 0.22%

CHEK -0.99%

CNTG -3.80%

CSTL 2.88%

DMTK -11.32%

DRIO 1.71%

EXAS -5.03%

FLDM -7.02%

FLGT -2.39%

GENE 1.35%

GH -0.59%

GTH 0.12%

HTGM 0.00%

ICLR 0.08%

IDXX -1.37%

ILMN -1.95%

ISPC -1.87%

LAB 0.00%

LMDX 0.00%

MDXH 0.84%

ME -7.58%

MEDP -2.94%

MYGN 0.62%

MYNZ -14.13%

NDRA -5.73%

NEO 3.97%

NEOG -2.07%

NOTV -4.05%

NTRA -1.56%

OCDX 0.92%

OLK 0.75%

OPGN 0.39%

OPK -0.79%

PMD 2.11%

PRPO 4.85%

PSNL -3.31%

RDNT 0.03%

SERA 3.50%

SHC -0.25%

SQL 0.00%

STIM -1.10%

STRR 2.71%

STRRP 8.67%

SYNH 0.02%

TRIB 2.90%

TTOO -1.66%

TWST 3.79%

VIVO 0.00%

XGN -1.62%

Koreliacija (AI algo v.1.1b): Undervalued: 0.25% $25.55 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: -0.60 (weak negative)

Trumpas: 0.89 (strong)

Signal:(62.938) Same movement expected

Olink Holding AB (publ) Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
ERIC	0.828
BIIB	0.824
EGAN	0.824
IBEX	0.816
AMCX	0.814
SSBK	0.813
MRBK	0.809
BIOL	0.807
KRKR	0.805
MNTX	0.804

10 Labiausiai neigiamai susiję koreliacijos
EZPW	-0.836
OWL	-0.834
ABUS	-0.83
FAAR	-0.811
PFTA	-0.806

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Olink Holding AB (publ) Koreliacija - Valiuta/Žaliavos

0.74
( moderate )

0.73
( moderate )

0.00
( neutral )

-0.50
( weak negative )

Olink Holding AB (publ) Finansinės ataskaitos

Annual	2023
Pajamos:	$169.91M
Bruto pelnas:	$98.87M (58.19 %)
EPS:	$-0.260

FY	2023
Pajamos:	$169.91M
Bruto pelnas:	$98.87M (58.19 %)
EPS:	$-0.260

FY	2022
Pajamos:	$139.85M
Bruto pelnas:	$94.50M (67.57 %)
EPS:	$-0.110

FY	2021
Pajamos:	$94.97M
Bruto pelnas:	$58.21M (61.29 %)
EPS:	$-0.322

Financial Reports:

No articles found.

Olink Holding AB (publ) Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Olink Holding AB (publ)

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. The company's products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and bioinformatics services. In addition, it provides Olink normalized protein expression (NPX) Manager, a purpose-built software that enable users to import data, validate data quality, and normalize for subsequent statistical analysis; and Olink Insight, a cloud platform for data visualization and statistical analysis of NPX data. Olink Holding AB (publ) sells its products and services through its own direct sales force in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. The company was founded in 2004 and is headquartered in Uppsala, Sweden. Olink Holding AB (publ) is a subsidiary of Summa Equity Holding AB.